𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CDP870 in Crohn's disease: Reconsidering Endpoints

✍ Scribed by Trevor A. Winter; Willem J. S. de Villiers; Houssam E. Mardini


Book ID
110087370
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
49 KB
Volume
12
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Endpoints for clinical trials evaluating
✍ Geert R. D'Haens; Richard Fedorak; Marc LΓ©mann; Brian G. Feagan; Michael A. Kamm πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 1 views

The management of Crohn's disease is rapidly changing. The advent of potent immunomodulatory and biologic therapies has led to more demanding endpoints for clinical trials than only clinical response and remission. Complete withdrawal of corticosteroids, healing of endoscopically visible lesions, an

Crohn's disease in childhood
✍ I. R. Sanderson; J. A. Walker-Smith πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 499 KB πŸ‘ 3 views

Schiff' first described a series of children with Crohn's disease in New York in 1945. He took care to exclude other diseases of the gastrointestinal tract with which it might clinically have been mistaken; these included infections by enteropathogenic bacteria and infestations with giardia and amoe

Endocarditis in Crohn's disease
✍ Charles Berkelhammer; Jelena Andrejic; Asim Mohammed πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 93 KB